Literature DB >> 31965374

Extent of Peritoneal Resection for Peritoneal Metastases: Looking Beyond a Complete Cytoreduction.

Aditi Bhatt1, Olivier Glehen2.   

Abstract

Completeness of cytoreduction is one of the most important prognostic factors impacting outcomes of cytoreductive surgery (CRS). To what extent the surrounding normal peritoneum needs to be removed is not known. We hypothesized that the extent of peritoneal resection should be different for different tumors and performed this study to find evidence to support this rationale. To determine the extent of resection of surrounding tissue for any tumor, the mechanisms of tumor development and spread, tumor morphology, the possibility of finding disease in the surrounding normal tissue, and the pattern of lymph node metastases should be known. Surgical resections also depend on patterns of recurrence and the impact of varying extent of resection on survival. We performed a review of literature pertaining to pathways and patterns of peritoneal cancer spread to determine the scientific basis for the extent of peritonectomy. We also reviewed studies comparing less and more extensive peritoneal resection. There is no consensus on the extent of lymphadenectomy required for most PM. Based on this review, we provide recommendations for the extent of peritoneal resection and the extent of lymph node dissection that should be performed for some common peritoneal tumors and identify areas that require further research. We propose that a systematic method of synoptic reporting of pathological specimens of CRS should be developed to capture information regarding the disease distribution within the peritoneal cavity and morphology of PM from different tumors. This can in future be used to establish standard guidelines for such resections.

Entities:  

Mesh:

Year:  2020        PMID: 31965374     DOI: 10.1245/s10434-020-08208-z

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  7 in total

Review 1.  Primary and metastatic peritoneal surface malignancies.

Authors:  Delia Cortés-Guiral; Martin Hübner; Mohammad Alyami; Aditi Bhatt; Wim Ceelen; Olivier Glehen; Florian Lordick; Robert Ramsay; Olivia Sgarbura; Kurt Van Der Speeten; Kiran K Turaga; Manish Chand
Journal:  Nat Rev Dis Primers       Date:  2021-12-16       Impact factor: 52.329

Review 2.  Imaging of pre- and post-cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pediatric intraperitoneal malignancy.

Authors:  Nathan C Hull; Candace F Granberg; Patricio C Gargollo; Paul G Thacker
Journal:  Pediatr Radiol       Date:  2022-10-07

Review 3.  Advances in the management of peritoneal malignancies.

Authors:  Vahan Kepenekian; Aditi Bhatt; Julien Péron; Mohammad Alyami; Nazim Benzerdjeb; Naoual Bakrin; Claire Falandry; Guillaume Passot; Pascal Rousset; Olivier Glehen
Journal:  Nat Rev Clin Oncol       Date:  2022-09-07       Impact factor: 65.011

Review 4.  Current Trends in Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Disease from Appendiceal and Colorectal Malignancies.

Authors:  Megan M Harper; Joseph Kim; Prakash K Pandalai
Journal:  J Clin Med       Date:  2022-05-18       Impact factor: 4.964

5.  Patterns of peritoneal dissemination and response to systemic chemotherapy in common and rare peritoneal tumours treated by cytoreductive surgery: study protocol of a prospective, multicentre, observational study.

Authors:  Aditi Bhatt; Pascal Rousset; Dario Baratti; Daniele Biacchi; Nazim Benzerdjeb; Ignace H J T de Hingh; Marcello Deraco; Vadim Gushchin; Praveen Kammar; Daniel Labow; Edward Levine; Brendan Moran; Faheez Mohamed; David Morris; Sanket Mehta; Aviram Nissan; Mohammad Alyami; Mohammad Adileh; Shoma Barat; Almog Ben Yacov; Kurtis Campbell; Kathleen Cummins-Perry; Delia Cortes-Guiral; Noah Cohen; Loma Parikh; Samer Alammari; Galal Bashanfer; Anwar Alshukami; Kaushal Kundalia; Gaurav Goswami; Vincent van de Vlasakker; Michelle Sittig; Paolo Sammartino; Armando Sardi; Laurent Villeneuve; Kiran Turaga; Yutaka Yonemura; Olivier Glehen
Journal:  BMJ Open       Date:  2021-07-05       Impact factor: 2.692

6.  Comparison of model fit and discriminatory ability of M category as defined by the 7th and 8th editions of the tumor-node-metastasis classification of colorectal cancer and the 9th edition of the Japanese classification.

Authors:  Dai Shida; Narikazu Boku; Yuya Nakamura; Takefumi Yoshida; Taro Tanabe; Kohei Yasui; Atsuo Takashima; Yukihide Kanemitsu
Journal:  Cancer Med       Date:  2021-09-29       Impact factor: 4.452

7.  Is Routine Gastroscopy/Colonoscopy Reasonable in Patients With Suspected Ovarian Cancer: A Retrospective Study.

Authors:  Guochen Liu; Junping Yan; Shanshan Long; Zhimin Liu; Haifeng Gu; Hua Tu; Jundong Li
Journal:  Front Oncol       Date:  2021-07-01       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.